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The hematopoietic-specific adaptor protein Gads functions in 
T-cell signaling via interactions with the SLP-76 and LAT adaptors
Stanley K. Liu*, Nan Fang†, Gary A. Koretzky† and C. Jane McGlade*
Background: The adaptor protein Gads is a Grb2-related protein originally
identified on the basis of its interaction with the tyrosine-phosphorylated form of
the docking protein Shc. Gads protein expression is restricted to hematopoietic
tissues and cell lines. Gads contains a Src homology 2 (SH2) domain, which has
previously been shown to have a similar binding specificity to that of Grb2. Gads
also possesses two SH3 domains, but these have a distinct binding specificity
to those of Grb2, as Gads does not bind to known Grb2 SH3 domain targets.
Here, we investigated whether Gads is involved in T-cell signaling.
Results: We found that Gads is highly expressed in T cells and that the SLP-76
adaptor protein is a major Gads-associated protein in vivo. The constitutive
interaction between Gads and SLP-76 was mediated by the carboxy-terminal
SH3 domain of Gads and a 20 amino-acid proline-rich region in SLP-76. Gads
also coimmunoprecipitated the tyrosine-phosphorylated form of the linker for
activated T cells (LAT) adaptor protein following cross-linking of the T-cell
receptor; this interaction was mediated by the Gads SH2 domain.
Overexpression of Gads and SLP-76 resulted in a synergistic augmentation of
T-cell signaling, as measured by activation of nuclear factor of activated T cells
(NFAT), and this cooperation required a functional Gads SH2 domain.
Conclusions: These results demonstrate that Gads plays an important role in 
T-cell signaling via its association with SLP-76 and LAT. Gads may promote
cross-talk between the LAT and SLP-76 signaling complexes, thereby coupling
membrane-proximal events to downstream signaling pathways.
Background
The engagement of the T-cell receptor (TCR)–CD3
complex activates the Src-family tyrosine kinases p56lck
and p59fyn which rapidly phosphorylate immunoreceptor
tyrosine-based activation motif (ITAM) sequences found
in the intracellular domains of the CD3 chains [1–4].
Phosphorylation of the tyrosine residues in the CD3ζ
chain ITAMs establishes a binding site for the tandem Src
homology 2 (SH2) domain-containing protein tyrosine
kinase ZAP-70 [5–9]. ZAP-70 is subsequently tyrosine-
phosphorylated by p56lck, which leads to the upregulation
of ZAP-70 kinase activity [10,11]. Activated Src-family
tyrosine kinases and ZAP-70 tyrosine kinases phosphory-
late downstream substrates, such as phospholipase Cγ1
(PLCγ1) [12], the proto-oncogene Vav [13], Cbl [14], SLP-
76 [15], and LAT (linker for activation of T cells) [16–19],
thereby initiating signaling cascades that culminate in the
activation of cytokine gene transcription through the acti-
vation of transcription factors such as nuclear factor of acti-
vated T cells (NFAT) [1–4].
These complex signaling pathways require the assembly of
multiprotein complexes through adaptor molecules such as
SLP-76 and LAT [20]. Both of these proteins assemble
phosphorylation-dependent and phosphorylation-indepen-
dent signaling complexes through their interaction with
enzymes and adaptor proteins that contain SH2 and SH3
domains. The hematopoietic-specific adaptor protein 
SLP-76 was originally identified as a tyrosine-phosphory-
lated protein in activated T cells that interacts in vitro with
a recombinant form of the Grb2 adaptor protein [15]. Over-
expression of SLP-76 in T cells has been demonstrated to
enhance both TCR-mediated extracellular-signal-regu-
lated kinase (ERK) activation, and NFAT-mediated acti-
vation of the interleukin-2 (IL-2) promoter and the NFAT
response element, suggesting a function for SLP-76 in cou-
pling proximal signaling events with distal transcriptional
events [21–23]. Recently, Clements et al. [24] and Pivniouk
et al. [25] reported that SLP-76-deficient mice lack periph-
eral T cells due to a block in thymic development at the
stage when pre-TCR signaling begins (that is, when thy-
mocytes express neither the CD4 or CD8 cell-surface
markers and are classed as ‘double-negative’), demonstrat-
ing an essential role for SLP-76 in signaling from the pre-
TCR during normal T-cell development. In addition,
experiments with a SLP-76-deficient Jurkat T-cell line
have shown that the tyrosine phosphorylation of PLCγ1,
activation of ERK and calcium mobilization all require
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SLP-76 function, suggesting that SLP-76 is required to
achieve sufficient activation of both the Ras-dependent
and calcium-dependent T-cell signaling pathways [26].
Presumably SLP-76 modulates these pathways via its
interaction with additional signaling proteins such as Vav,
Grb2 and SLAP-130/FYB [15,27–29]. The mechanism by
which SLP-76 is coupled to the TCR and how it acts to
modulate multiple pathways is not clear, however.
The recently cloned membrane-associated protein pp36
LAT is highly phosphorylated on tyrosine residues follow-
ing TCR engagement [18,19]. LAT possesses several
tyrosine residues within consensus binding sites for the
SH2 domains of Grb2 and PLCγ1 [19]. It has been pro-
posed that the tyrosine phosphorylation of LAT initiates
both Ras-dependent and calcium-dependent signaling
pathways through the recruitment of the complex of Grb2
and the Sos guanine nucleotide exchange factor, and of
PLCγ1, respectively [16,19,30].
Grb2 is a small adaptor protein composed of one SH2 and
two flanking SH3 domains, and has been shown to link
activated growth factor receptors to Ras activation through
its interaction with Sos [31–33]. Growth-factor-dependent
receptor activation and autophosphorylation, or tyrosine
phosphorylation of docking proteins such as Shc, generates
specific binding sites for the SH2 domain of Grb2. The
Grb2 SH3 domains mediate the stable association with
proline-based motifs in Sos, thereby recruiting Sos to the
receptor complex following activation. In T cells, Grb2 is
also associated with Sos [30,34], and various models have
been proposed for SH2-domain-mediated Grb2–Sos
translocation to the membrane, such as TCR–Shc-medi-
ated recruitment [35] or, as more recently proposed,
recruitment of Grb2–Sos by the membrane-associated
LAT protein [16–19]. Grb2 has also been demonstrated to
associate via its SH3 domains with Cbl and SLP-76 [36],
suggesting that Grb2 may couple the TCR to pathways
other than Ras. Whether Grb2 association with these addi-
tional SH3-domain-binding proteins is of functional
importance in TCR signaling has not been elucidated.
The adaptor protein Gads (Grb2-related adaptor down-
stream of Shc) was originally identified as a Grb2-related
protein that interacts with tyrosine-phosphorylated Shc
[37]. The Gads SH2 domain appears to have a similar
binding specificity to that of Grb2 and the related protein
Grap (Grb2-related adaptor protein) [38,39], binding to Shc
and the Bcr–Abl fusion protein, but displays a distinct SH3-
domain-binding specificity. On the basis of the observation
that Gads does not bind to Sos or other known Grb2 SH3
domain targets, Gads has been proposed to couple common
upstream tyrosine-phosphorylated proteins to novel down-
stream targets. In this report, we demonstrate that Gads is
highly expressed in T cells and binds to two important
components of TCR signaling — LAT and SLP-76. 
Furthermore, we have found that SLP-76 and Gads act
synergistically to augment NFAT activation. These results
suggest that Gads plays an important role in T-cell signal-
ing through its association with SLP-76 and LAT.
Results
Gads is expressed in hematopoietic cells
We have previously determined by northern blot analysis
that Gads expression is largely restricted to hematopoietic
tissues and that Gads is abundantly expressed in both
murine CTLL2 and human Jurkat, MOLT4 and K562
cells [37]. To determine whether the Gads protein is
expressed in additional hematopoetic lineages, primary
hematopoietic cells or hematopoietic cell lines were lysed
and subjected to immunoprecipitation with anti-Gads
antibodies, followed by immunoblotting with anti-Gads
antibodies. As previously observed, Gads was highly
expressed in Jurkat T cells and, in addition, was detected
in the MO7E megakaryocytic cell line, as well as in both
primary bone-marrow-derived mast cells and primary T
cells. Gads expression was undetectable in HCD-57 ery-
throid, P815 mastocytoma, or Raji B lymphoblast cell lines
(Figure 1). In addition, Gads expression was detected in
natural killer (NK) and macrophage cell lines by immuno-
precipitation with anti-Gads antibodies (our unpublished
observations). These results suggest that Gads expression
is restricted to T lymphocytes, megakaryocytes, mast
cells, NK cells and macrophages.
Gads is associated with tyrosine-phosphorylated SLP-76
and LAT following TCR stimulation
As Gads is most highly expressed in both primary T cells
and T-cell lines, we were interested in examining a possi-
ble role for Gads in T-cell signaling. Lysates from
68 Current Biology, Vol 9 No 2
Figure 1
Expression of Gads protein in primary hematopoietic cells and
hematopoietic cell lines. Cells from the cell lines HCD-57 (murine
erythroleukemia), P815 (murine mastocytoma), MO7E (human
megakaryocytic cells), Jurkat (human T-cell leukemia) and Raji 
(B lymphoblast), and primary murine bone-marrow-derived mast cells
(BMMC) and primary T cells (lymph-node-derived primary murine T
cells) were lysed; 500 µg of each lysate was immunoprecipitated
with anti-Gads antibodies, separated by SDS–PAGE and
immunoblotted with anti-Gads antibodies. The migration of human
and murine Gads is indicated.
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Human Gads
unstimulated or anti-CD3-stimulated Jurkat T cells were
subjected to immunoprecipitation with anti-Gads anti-
body, and the presence of phosphotyrosine-containing
proteins in the immunoprecipitates was assessed by anti-
phosphotyrosine immunoblotting. A coimmunoprecipitat-
ing tyrosine-phosphorylated protein of 76 kDa was
detected prior to anti-CD3 stimulation, and additional
36 kDa and 42 kDa phosphoproteins appeared after stim-
ulation in the anti-Gads immunoprecipitates but not in
control immunoprecipitations using rabbit anti-mouse
IgG or protein A alone (Figure 2a). Increased tyrosine
phosphorylation of the 76 kDa protein was observed fol-
lowing anti-CD3 stimulation (Figure 2a). Similarly, a pre-
dominant tyrosine-phosphorylated protein of 76 kDa
coimmunoprecipitated with Gads after anti-CD3
crosslinking of primary murine lymphocytes (Figure 2a).
To identify the tyrosine-phosphorylated proteins associ-
ated with Gads, anti-Gads immunoprecipitations were
performed using unstimulated and anti-CD3-stimulated
Jurkat T-cell lysates, and the immunoprecipitates were
immunoblotted with antibodies against known proteins of
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Gads associates with SLP-76 and LAT in T cells. (a) Association of
Gads with tyrosine-phosphorylated proteins in anti-CD3-stimulated
Jurkat T cells and primary lymph-node-derived T cells. Jurkat T cells
(2 × 107 cell equivalents per condition) were left unstimulated or were
stimulated with soluble anti-CD3ε antibody for 2 min, lysed and
immunoprecipitated with protein A–Sepharose alone (PAS), rabbit
anti-mouse IgG (RαM), or anti-Gads antibodies. Following
SDS–PAGE and transfer of proteins to Immobilon, the protein
complexes were analyzed by anti-phosphotyrosine immunoblotting
(anti-pY; top left). The blot was stripped and reprobed with anti-Gads
antibodies (bottom left). Similarly, murine T cells were freshly isolated
from lymph nodes, and 7.5 × 106 T lymphocytes were left unstimulated
or were stimulated with soluble anti-CD3ε antibody for 2 min, lysed
and immunoprecipitated with anti-Gads antibodies, and analyzed by
anti-phosphotyrosine immunoblotting as above (top right). The blot
was stripped and reprobed with anti-Gads antiserum (bottom right).
(b–d) Gads associates with SLP-76 and LAT. (b) Jurkat T cells were
left unstimulated or were stimulated with soluble anti-CD3ε antibody,
lysed and immunoprecipitated with anti-Gads, anti-Grb2 or anti-SLP-
76 antibodies. Immunoprecipitates were separated by SDS–PAGE,
transferred to Immobilon, and immunoblotting was performed with anti-
SLP-76, anti-Gads or anti-Grb2 antibodies (as indicated). Total cell
lysate (lysate) was also analyzed. (c) Jurkat T cells were left
unstimulated or were stimulated with soluble anti-CD3ε antibody, lysed
and immunoprecipitated with anti-Sos1, anti-Gads, or anti-Grb2
antibodies. The immunoprecipitates were separated by SDS–PAGE,
transferred to Immobilon, and immunoblotting was performed with anti-
Sos1, anti-Gads or anti-Grb2 antibodies (as indicated). Total cell
lysate (lysate) was also analyzed. (d) Jurkat T cells were left
unstimulated or were stimulated with soluble anti-CD3ε antibody,
lysed, and immunoprecipitated with anti-Gads antibodies, followed by
immunoblotting with anti-LAT antibodies (top). Subsequently, the blot
was stripped and reprobed with anti-Gads antibodies (bottom). Total
cell lysate (lysate) was also analyzed.
the corresponding molecular weights. Anti-SLP-76 anti-
bodies recognized the 76 kDa protein in anti-Gads
immunoprecipitates from both unstimulated and stimu-
lated lysates (Figure 2b). Similarly, Gads protein was
detected in anti-SLP-76 immunoprecipitates from both
unstimulated and stimulated Jurkat cells by anti-Gads
immunoblotting. In agreement with previous reports, a
complex between endogenous Grb2 and SLP-76 was not
detected (Figure 2b). As SLP-76 was originally identified
as a Grb2-binding protein, we asked whether another
major Grb2-binding protein — Sos — was associated with
Gads in Jurkat T cells. No Sos-immunoreactive bands
were detected in anti-Gads immunoprecipitates, whereas
Sos was clearly present in anti-Grb2 immunoprecipitates
from the same experiment (Figure 2c). These results
suggest that the binding specificities of Grb2 and Gads are
not entirely the same.
Anti-LAT antibodies detected a 36 kDa protein only in
anti-Gads immunoprecipitates from stimulated lysates
(Figure 2d). Stripping the blot and reprobing with anti-
phosphotyrosine antibodies verified that SLP-76-
immunoreactive and LAT-immunoreactive bands
corresponded to the respective 76 kDa and 36 kDa tyro-
sine-phosphorylated proteins previously detected in anti-
Gads immunoprecipitates (data not shown). Together,
these experiments indicate that SLP-76 is constitutively
associated with Gads, whereas the association of LAT
with Gads occurs following TCR ligation.
Mapping of the Gads domains required for interaction with
SLP-76 and LAT
To define the region of Gads that interacts with SLP-76,
recombinant full-length glutathione S-transferase
(GST)–Gads fusion proteins containing inactivating point
mutations in the SH3 or SH2 domains [37] were assessed for
their ability to interact with tyrosine-phosphorylated pro-
teins from anti-CD3 stimulated Jurkat T-cell lysates
(Figure 3a). The major tyrosine-phosphorylated protein cor-
responding to SLP-76 was not precipitated by the
GST–Gads mutant proteins in which both SH3 domains or
the carboxy-terminal SH3 domain alone were inactivated,
suggesting that the carboxy-terminal SH3 domain is
required for the interaction between Gads and SLP-76.
GST–Gads mutant proteins with an inactivated SH2
domain did not precipitate the 36 kDa tyrosine-phosphory-
lated protein corresponding to LAT, demonstrating that the
Gads–LAT interaction requires a functional Gads SH2
domain. No change in the profile of tyrosine-phosphorylated
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Figure 3
Mapping of the Gads domains mediating the interaction with SLP-76
and LAT. (a) The carboxy-terminal SH3 domain of Gads mediates
binding to SLP-76, and the SH2 domain of Gads mediates binding to
LAT. Lysates from Jurkat T cells stimulated with soluble anti-CD3ε
antibody were incubated with purified, immobilized GST or GST fusion
proteins of wild-type Gads (WT) or Gads mutants containing
inactivating mutations of both SH3 domains (N*/C* SH3), the amino-
terminal SH3 domain (N*/C SH3), the carboxy-terminal SH3 domain
(N/C* SH3) or the SH2 domain (SH2*). The protein complexes were
separated by SDS–PAGE and immunoblotted with anti-
phosphotyrosine antibodies (anti-pY). The identity of the tyrosine-
phosphorylated proteins marked as SLP-76 and LAT was confirmed by
stripping and reprobing with anti-SLP-76 and anti-LAT antisera (data
not shown). (b) Transiently expressed Gads mutants fail to bind 
SLP-76 and LAT. Jurkat T cells were transfected with the pEF-FLAG
expression vector or pEF-FLAG vectors in which wild-type Gads (WT)
or Gads mutants with inactivating mutations in both SH3 domains
(N*/C* SH3) or the SH2 domain (SH2*) were fused in-frame with the
FLAG epitope tag. Cells were left unstimulated or stimulated with
soluble anti-CD3ε antibody 24 h after transfection, lysed,
immunoprecipitated with anti-FLAG antibodies and analyzed by anti-
phosphotyrosine immunoblotting (anti-pY). The identities of the
tyrosine-phosphorylated proteins marked as SLP-76 and LAT were
confirmed by stripping and reprobing with anti SLP-76 and anti-LAT
antibodies. Expression of the FLAG-tagged Gads proteins was
determined by immunoblotting with anti-Gads antibodies.
proteins bound by a Gads mutant with an inactivating muta-
tion in the amino-terminal SH3 domain was observed
(Figure 3a). These results were supported by the observa-
tion that GST fusion proteins consisting of the isolated Gads
carboxy-terminal SH3 domain and SH2 domain were suffi-
cient for binding to SLP-76 and LAT, respectively, from
anti-CD3 stimulated Jurkat T-cell lysate (data not shown).
To confirm these results in vivo, Jurkat T cells were tran-
siently transfected with cDNAs encoding FLAG-epitope-
tagged wild-type Gads or Gads mutants with inactivated
SH3 or SH2 domains. FLAG immunoprecipitations from
unstimulated and anti-CD3-stimulated cells were subse-
quently assayed for the presence of coprecipitating
SLP-76 and LAT. Consistent with the results obtained in
vitro, inactivation of the Gads SH3 domains abrogated the
in vivo association between Gads and SLP-76, whereas
inactivation of the Gads SH2 domain resulted in a loss of
LAT association in vivo (Figure 3b).
The 224—244 amino-acid region of SLP-76 is required for
binding to Gads
As the Gads carboxy-terminal SH3 domain was responsi-
ble for mediating the interaction with SLP-76, we tested
whether sequences within the proline-rich region of SLP-
76 contained the binding site. Recombinant GST fusion
proteins containing various regions of the proline-rich
domain of SLP-76 were incubated with Jurkat T-cell
lysates and immunoblotted for the presence of Gads
(Figure 4a). GST fusion proteins corresponding to amino
acids 225–265 or 225–275 of SLP-76 were able to precipi-
tate Gads, whereas fusion proteins containing regions
carboxy-terminal to amino acid 235 did not precipitate
Gads. This suggests that the Gads-binding site resides
between amino acids 225–235. To determine whether this
region is required for interaction with Gads in vivo, tran-
sient transfection of cDNAs corresponding to FLAG-
tagged wild-type SLP-76 or a FLAG-tagged SLP-76
mutant lacking amino acids 224–244 were performed in
Jurkat T cells, and the interaction of the FLAG-tagged
SLP-76 with endogenous Gads was assessed (Figure 4b).
Unlike wild-type SLP-76, the mutant SLP-76 was unable
to coimmunoprecipitate Gads, indicating that the 224–244
amino-acid region of SLP-76 is responsible for interacting
with Gads in vivo. Deletion of amino acids 1–156 of SLP-
76, a region that contains the major sites of tyrosine phos-
phorylation, had no effect on Gads binding.
Gads synergizes with SLP-76 to augment NFAT activity
Transcription of the IL-2 gene following TCR ligation is
an essential component of the T-cell activation process.
This event is mediated in part by the activation and
binding of the NFAT transcription factor to the IL-2 pro-
moter. The transient overexpression of SLP-76 has been
previously demonstrated to enhance transcription of a
luciferase reporter gene driven by the NFAT-binding
region of the IL-2 promoter in response to TCR ligation
[22]. On the basis of the observation that SLP-76 is a major
binding partner for Gads, we examined whether Gads may
be involved in a signaling pathway coupling TCR activa-
tion to the distal activation of NFAT and IL-2. To explore
this possibility, Jurkat T cells were transiently cotrans-
fected with a reporter plasmid containing the luciferase
gene driven by the IL-2 NFAT-binding site together with
FLAG-tagged Gads and/or FLAG–SLP-76 expression
constructs (Figure 5a). Overexpression of wild-type Gads
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Figure 4
Mapping of the Gads-binding site on SLP-76. (a) Mapping of the
Gads-binding site on SLP-76 to amino acids 224–244. Purified
immobilized GST fusion proteins corresponding to regions spanning
the proline-rich region of SLP-76 were incubated with Jurkat T-cell
lysate and the bound proteins analyzed by SDS–PAGE and
immunoblotting with anti-Gads antibodies. The corresponding amino
acids from SLP-76 encoded by each fusion protein are indicated. 
(b) A SLP-76 mutant lacking amino acids 224–244 does not interact
with Gads. Jurkat T cells were transfected with the pEF-FLAG–SLP-76
(WT) or pEF-FLAG vectors encoding mutant SLP-76 proteins with a
deletion of amino acids 1–156 (∆1–156), or a deletion of amino acids
224–244 (∆20). The cells were lysed and immunoprecipitated with
anti-FLAG antibodies 24 h after transfection. Total cell lysates or
immunoprecipitates (IP: FLAG) were analyzed by immunoblotting with
anti-Gads (upper panel) or anti-FLAG antibodies (lower panel).
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did not appear to influence activation of the NFAT-driven
reporter gene following stimulation with either anti-TCR
antibodies or anti-TCR antibodies plus phorbol myristate
acetate (PMA); wild-type SLP-76 overexpression resulted
in enhanced NFAT activation as previously reported [22].
Coexpression of both SLP-76 and wild-type Gads resulted
in the synergistic activation of NFAT (Figure 5a), suggest-
ing that Gads functions in concert with SLP-76 to activate
NFAT. This synergistic influence of Gads and SLP-76
coexpression was also observed using a luciferase reporter
gene driven by the full-length IL-2 promoter (Figure 5b).
A functional SH2 domain was essential for Gads to syner-
gize with SLP-76 because the Gads SH2 mutant (SH2*)
failed to augment, and in fact appeared to inhibit, NFAT
activation when transiently expressed either alone or in
combination with SLP-76 (Figure 5c).
Discussion
Several adaptor proteins have been shown to play an
essential role in coupling membrane proximal events fol-
lowing TCR ligation to downstream signaling pathways.
The membrane-anchored LAT adaptor protein is
believed to provide a route to Ras activation through the
recruitment of Grb2–Sos and Grap–Sos complexes
[16,19,38] and to initiate calcium-dependent signals
through its association with PLCγ. The SH2 and SH3
domains of both Grb2 and Grap adaptor proteins have
overlapping binding specificities and accordingly have
been demonstrated to associate with common proteins
such as LAT, Sos, Cbl and dynamin [19,38,39]. Their
overlapping binding specificities have led to the hypothe-
sis that Grb2 and Grap may serve to amplify common sig-
naling pathways following TCR engagement [38]. In this
report, we have explored the function of a new Grb2-
related adaptor protein, Gads, in T cells. Gads does not
interact with Sos but rather associates with the hematopoi-
etic-specific proteins LAT and SLP-76, suggesting that
Gads may have a specific role in TCR signaling, distinct
from that of Grb2 or Grap. In addition, our study provides
evidence for the relevance of Gads in TCR signaling,
because we found that Gads and SLP-76 synergize to
augment TCR-mediated NFAT and IL-2 gene activation.
We have previously reported that, although the binding
specificity of the Gads SH2 domain is similar to that of the
Grb2 SH2 domain, the binding specificity of the Gads
SH3 domain appears to be distinct [37]. In Jurkat T cells,
we have found that Gads is constitutively associated with
SLP-76, while inducibly associating with LAT following
TCR ligation. The interaction between Gads and LAT is
mediated through the Gads SH2 domain. LAT possesses
five tyrosine residues which, if phosphorylated, conform
to the consensus binding motif (pYXNX; where X repre-
sents any amino acid and pY represents a phosphorylated
72 Current Biology, Vol 9 No 2
Figure 5
NFAT–luc
Vector SLP-76 Gads SLP-76
+ Gads
0
20
40
60
80
100
120
P
er
ce
nt
ag
e 
of
 m
ax
im
um
Vector SLP-76 Gads SLP-76
+ Gads
0
10
20
30
40
50
60
70
P
er
ce
nt
ag
e 
of
 m
ax
im
um
P
er
ce
nt
ag
e 
of
 m
ax
im
um

Current Biology   
Unstimulated Anti-TCR Anti-TCR+PMA
IL-2–luc
Ve
cto
r
SL
P-
76
Ga
ds
 W
T
Ga
ds
 S
H2
*
SL
P-
76
+G
ad
s W
T
SL
P-
76
+G
ad
s S
H2
*0
10
20
30
40
50
60
(a) (b) (c) NFAT–luc
Gads synergizes with SLP-76 to augment NFAT and IL-2 promoter
activity. (a) Jurkat T cells were transiently cotransfected with a reporter
plasmid containing the luciferase gene driven by the NFAT-binding site
from the IL-2 promoter (NFAT–luc) and either empty pEF-FLAG vector
or FLAG-tagged SLP-76, Gads or Gads and SLP-76. The cells were
stimulated 24 h after transfection with media (unstimulated), anti-TCR
monoclonal antibody C305 (ascites 1:1000) or anti-TCR antibody plus
PMA (50 ng/ml) for 8 h, and assayed for luciferase activity. The results
(mean of triplicates) are expressed as the percentage of arbitrary
luciferase units induced by PMA (50 ng/ml) plus ionomycin treatment
(1 µM; percentage of maximum). (b) Jurkat cells were transfected and
analyzed as in (a) except that a reporter plasmid containing the
luciferase gene driven by the full-length IL-2 promoter (IL-2–luc) was
used. (c) The Gads SH2 domain is required for synergistic activation
of NFAT. Jurkat T cells were transiently cotransfected with the
NFAT–luciferase reporter vector (NFAT–luc) together with either
empty vector or FLAG-tagged SLP-76 or wild-type Gads (Gads WT)
or the Gads SH2 domain mutant (Gads SH2*), with or without 
SLP-76. The cells were stimulated 24 h after transfection with media
(unstimulated), anti-TCR monoclonal antibody C305 or anti-TCR
antibody plus PMA and assayed for luciferase activity. The results
(mean of triplicates) are expressed as the percentage of arbitrary
luciferase units induced by PMA plus ionomycin treatment (percentage
of maximum).
tyrosine residue) for the Grb2 SH2 domain. Two of these
sites (Y171 and Y191) have been shown to be critical for
association with Grb2 [19]. On the basis of the previously
demonstrated binding specificity of the Gads SH2
domain, we postulate that Gads may bind to some of the
predicted Grb2-binding sites in LAT.
The constitutive interaction between Gads and SLP-76
was mapped to the carboxy-terminal SH3 domain of Gads,
and a 20 amino-acid proline-rich sequence within SLP-76
(amino acids 224–244). Although this region does not
contain either a class I (RXXPPXP) or class II
(XPPXPXR) consensus SH3-domain-binding motif (in
single-letter amino-acid code where X represents any
amino acid) [40], it is equivalent to the region that has
been shown to bind to the Grb2 SH3 domain [15,22].
Studies are currently underway to determine which amino
acids in this region constitute the Gads SH3-domain-
binding motif. The mapping of the SH3-domain-binding
sites of both Gads and Grb2 to the same region of SLP-76
suggests that Gads and Grb2 could compete for binding to
SLP-76. Whereas a Gads–SLP-76 complex can readily be
detected in vivo, a Grb2–SLP-76 complex has been much
more difficult to detect, suggesting that Gads is a physio-
logically relevant SLP-76-binding protein and is more
abundantly found in a complex with SLP-76 in Jurkat T
cells. One possible explanation for this is the broader
SH3-domain-binding specificity of Grb2, which would
also promote its interaction with additional high-affinity
SH3-domain ligands in T cells — such as Sos and Cbl —
and reduce the pool of Grb2 bound to SLP-76. In keeping
with our previous observations in the K562 leukemia cell
line [37], the binding specificity of the Gads SH3 domains
in T cells also appears to be restricted, because SLP-76 is
the only phosphoprotein detected which requires an intact
Gads SH3 domain, and we have verified that Sos does not
bind Gads. The structural basis for the binding selectivity
of the SH3 domain of Gads is currently under investiga-
tion. An additional question that remains is the identifica-
tion of targets for the Gads amino-terminal SH3 domain,
as we have not detected any proteins that require this
domain for their interaction with Gads.
Two major tyrosine-phosphorylated proteins of 62 kDa and
130 kDa have been reported to associate with the SH2
domain of SLP-76 following TCR engagement [22].
Although the identity of the 62 kDa phosphoprotein
remains elusive, the 130 kDa phosphoprotein has been
cloned and termed SLAP-130/FYB [29,41]. SLAP-130 is
rapidly tyrosine-phosphorylated following TCR stimulation
and, aside from an SH3-like domain at its carboxyl termi-
nus, shows no homology to any known proteins [29,41].
The function of SLAP-130 in TCR signaling is not clear at
this time. We have not detected the presence of tyrosine-
phosphorylated 62 kDa or 130 kDa proteins in anti-Gads
immunoprecipitates following TCR stimulation, although
tyrosine-phosphorylated SLP-76 is abundantly present
(data not shown). This finding suggests that there may be
distinct pools of SLP-76 bound to either SLAP-130 or Gads.
In addition, the proto-oncogene Vav has been reported to
interact with tyrosine phosphorylated SLP-76 [27,28];
however, we did not detect a Vav–SLP-76–Gads complex
by anti-Vav immunoblotting of anti-Gads immunoprecipi-
tates following TCR crosslinking (data not shown).
Overexpression of SLP-76 has been shown to augment
NFAT and IL-2 activation in response to TCR ligation
[22]. This effect is probably due to its role both in
PLCγ1-mediated calcium mobilization and in ERK acti-
vation [26]. SLP-76 may therefore function to integrate
the activation of multiple signals from the TCR. We
observed that overexpression of wild-type Gads alone has
no effect on NFAT activation but, in combination with
overexpression of SLP-76, can enhance both NFAT and
IL-2 activation. The simplest interpretation of our results
is that Gads functions to couple SLP-76 to LAT, thereby
promoting cross-talk between these two signaling com-
plexes and activation of downstream signaling pathways.
Our results show that mutation of the Gads SH2 domain
abrogates the ability of Gads to bind to LAT and to syn-
ergize with SLP-76. In fact, the Gads SH2-domain
mutant appears to have an inhibitory effect on SLP-76,
perhaps functioning in a dominant-negative fashion
because it would still interact effectively with SLP-76
while uncoupling SLP-76 from LAT and other potential
SH2 domain targets.
Gads was originally identified in a search for new proteins
associated with tyrosine-phosphorylated Shc [37]. We have
previously shown an in vivo association between Gads and
tyrosine-phosphorylated Shc in K562 leukemic cells,
although we have not detected this interaction in the
context of activated Jurkat T cells. This is consistent with
previous reports that have failed to detect tyrosine phos-
phorylation of Shc or the formation of Shc–Grb2 com-
plexes in Jurkat T cells and primary human T lymphocytes
[30,42]. This does not preclude a functionally relevant
interaction between Shc and Gads in other hematopoietic
cell types or in alternative T-cell systems where Shc has
been shown to be robustly tyrosine phosphorylated and
Shc–Grb2 complexes have been detected [35].
We have shown that Gads is also expressed in the MO7E
megakaryocytic cell line, primary mast cells, NK cells and
macrophages, a pattern of expression that coincides with
the reported expression pattern of SLP-76 [15,43,44]. It
is therefore likely that a Gads–SLP-76 complex may be
important in signaling from activated receptors in these
additional hematopoietic lineages. Tyrosine-phosphory-
lated Shc or activated receptors such as c-Kit are poten-
tial targets of the Gads SH2 domain in these additional
cell lineages.
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Conclusions
We have demonstrated a role for the hematopoietic-specific
adaptor protein Gads in TCR signaling through an SH3-
domain-mediated interaction with SLP-76. Gads synergizes
with SLP-76 to augment NFAT activation, and a functional
SH2 domain is important for mediating this effect. As one
of the proteins that binds to the SH2 domain of Gads has
been identified as LAT, we propose a model whereby Gads
functions to promote cross-talk between the LAT and SLP-
76 signaling complexes. Given their overlapping expression
patterns, we anticipate a role for Gads–SLP-76 complexes
in additional hematopoietic lineages.
Materials and methods
Plasmids
Wild-type SLP-76, SLP-76 mutants and SLP-76 proline-rich GST fusion
constructs have been previously described [21–23]. Wild-type Gads
and Gads mutants were previously described in Liu and McGlade [37],
and subcloned in-frame with the FLAG epitope of the modified pEFBOS
vector (pEF-FLAG) [21]. The NFAT-driven luciferase reporter vector was
provided by J. Crabtree (Stanford University), and the IL-2 promoter-
driven luciferase reporter vector was a gift of R. Abraham (Mayo Clinic).
Cell culture
Jurkat and Raji cells were cultured in RPMI 1640 medium supple-
mented with 10% (v/v) fetal bovine serum (Gibco BRL), 200 mM L-glu-
tamine, 5 U/ml penicillin C and 5 mg/ml streptomycin sulfate. P815
cells were maintained in DMEM medium supplemented as above.
HCD-57 cells were maintained in Iscove’s media supplemented with
20% (v/v) fetal bovine serum, 200 mM L-glutamine, 5 U/ml penicillin C,
5 mg/ml streptomycin sulfate and 0.5 U/ml erythropoietin. MO7E cells
were maintained in RPMI 1640 medium supplemented with 20% (v/v)
fetal bovine serum, 200 mM L-glutamine, 5 U/ml penicillin C, 5 mg/ml
streptomycin sulfate and 100 U/ml GM-CSF. Primary mast cells were
isolated from murine bone marrow and cultured as previously
described in Reith et al. [45].
Preparation of GST fusion proteins
Recombinant GST fusion proteins were expressed and purified as previ-
ously described [46]. Purified proteins bound to glutathione–Sepharose
4B beads (Pharmacia) were resuspended in an equal volume of NP-40
lysis buffer (50 mM Hepes pH 7.4, 150 mM NaCl, 2 mM EDTA, 100 mM
ZnCl2, 1% (v/v) Nonidet-P40, 10% (v/v) glycerol) containing Complete
protease inhibitors (Boehringer-Mannheim) and 1 mM DTT and stored at
–80°C. Each of the purified GST fusion proteins was quantitated by
SDS–PAGE followed by Coomassie staining, and comparison with
BSA standards.
Transient transfections and luciferase reporter assays
For transient transfections, 2 × 107 Jurkat T cells were electroporated
with 80 µg of the indicated plasmids in serum-free RPMI 1640 with a
Gene Pulser (Bio Rad) set at 250 V and 960 µF. Jurkat T cells were
harvested 24 h later and processed as described below. For transient
transfection in luciferase assays, 1 × 107 Jurkat T cells were electropo-
rated with 20 µg IL-2–luciferase or NFAT–luciferase reporter construct,
together with 40 µg empty pEF-FLAG vector or pEF-FLAG–SLP-76
and/or pEF-FLAG–Gads vector, as indicated in each experiment. Tripli-
cates of 5 × 106 viable cells were stimulated 24 h after transfection, as
indicated, for 8 h at 37°C, lysed and luciferase activity quantitated with
a luminometer as previously described [21].
Antibodies
Affinity-purified polyclonal anti-Gads antibodies were described previ-
ously [37]. The monoclonal anti-phosphotyrosine antibody 4G10
(Upstate Biotechnology) was used at a dilution of 1:1000 for western
blot analysis. Anti-human SLP-76 polyclonal antisera [22] was used at
a 1:500 dilution for western blotting and 5 µg were used for immuno-
precipitations. Affinity-purified polyclonal anti-LAT antibodies were pur-
chased from Upstate Biotechnology and used for western blotting at a
dilution of 1:250. Anti-Sos1 polyclonal antibodies were purchased from
Santa Cruz Biotechnology with 4 µg used for immunoprecipitations
and a dilution of 1:250 for western blotting. For immunoprecipitations,
4 µg polyclonal anti-Grb2 antibodies (Santa Cruz Biotechnology) were
used and a 1:1000 dilution of monoclonal anti-Grb2 antibodies (Trans-
duction Laboratories) used for immunoblotting. In immunoprecipita-
tions, 5 µg monoclonal anti-FLAG M2 antibodies (Kodak) were used
and a 1:1000 dilution used for western blotting. Rabbit anti-mouse IgG
antibodies were purchased from Upstate Biotechnology and 4 µg used
in immunoprecipitations.
Immunoprecipitation and western blotting
For experiments utilizing Jurkat T cells, between 2 and 5× 107 Jurkat T
cells were resuspended in 500 µl RPMI 1640 medium, prewarmed at
37°C for 10 min, then left unstimulated or stimulated with 10µg soluble
anti-CD3ε antibody (UCHT1; Pharmingen) for 2 min at 37°C. Then
700 µl chilled phosphate-buffered saline (pH 7.2) containing phos-
phatase inhibitors (10 mM Na4P2O7, 100 mM NaF, 1 mM Na3VO4) was
added, and the cells collected by centrifugation, lysed and processed as
detailed below. Primary murine T cells were freshly isolated from lymph
nodes and stimulated with soluble anti-CD3ε antibody (20 µg/ml, clone
145-2C11, hamster IgG; PharMingen) for 2 min at 37°C. Cells were col-
lected by centrifugation and lysed in 1 ml PLC lysis buffer (50 mM
Hepes pH 7.5, 150 mM NaCl, 10% (v/v) glycerol, 1% (v/v) Triton X-100,
1.5 mM MgCl2, 1 mM EDTA, 10 mM Na4P2O7, 100 mM NaF, 1 mM
Na3VO4) containing Complete protease inhibitors and the lysate clarified
by centrifugation at 13,500 rpm at 4°C for 10 min. Clarified lysates were
incubated with antibodies as described above and 50 µl 20% (v/v)
protein G–Sepharose or protein A–Sepharose (Sigma) at 4°C with
gentle rotation for 90 min. Immune complexes were washed three times
with 1 ml NP-40 lysis buffer, bound proteins eluted by boiling for 5 min in
reducing SDS–Laemmli sample buffer and resolved by SDS–PAGE.
Proteins were electrophoretically transferred to Immobilon-P membrane
(Millipore), and incubated in a blocking solution of 5% non-fat skim milk
powder (w/v) in TBST (20 mM Tris-Base pH 7.5, 150 mM NaCl, 0.05%
(v/v) Tween-20) or in 1% BSA (w/v) in TBST (for anti-phosphotyrosine
western blotting) for a minimum of 1 h prior to addition of antibody for
1 h at room temperature. Membranes were washed three times in TBST
and incubated at room temperature for 1 h with an appropriate sec-
ondary antibody conjugated to horseradish peroxidase. Following incu-
bation with secondary antibodies, membranes were washed three times
in TBST and developed using enhanced chemiluminescence (Amer-
sham) according to the manufacturer’s instructions. 
In vitro binding experiments
The lysate of 2 × 107 Jurkat T cell equivalents was prepared as
described above, and incubated with approximately 5 µg GST fusion
protein coupled to glutathione-sepharose 4B beads for 90 min at 4°C.
The beads were washed three times with NP-40 lysis buffer, resus-
pended in reducing SDS–Laemmli sample buffer, the proteins resolved
by SDS–PAGE and transferred to Immobilon-P membrane. Western
blotting and detection of immunoreactive bands was carried out as
described above.
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